ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2022

November 10-14, 2022. Philadelphia, PA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z
  • Abstract Number: 0588
    S-nitrosoglutathione Reductase (GSNOR) Regulates Osteoclast Differentiation
  • Abstract Number: 0985
    S100 Serum Protein Expression Is a Useful Indicator of HCQ Treatment Efficacy in SLE
  • Abstract Number: 0757
    Safety and Effectiveness of Immune Checkpoint Inhibitors Combination versus Single Agent Therapy in Patients with Pre-existing Autoimmune Diseases
  • Abstract Number: 2016
    Safety and Efficacy Associated with Long-Term Low Dose Glucocorticoids in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
  • Abstract Number: 1598
    Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial
  • Abstract Number: 1074
    Safety and Efficacy of Dupilumab in Patients with Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis
  • Abstract Number: 0294
    Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biologic DMARDs: Results Through 5 Years from the SELECT-BEYOND Study
  • Abstract Number: 0295
    Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs: Results Through 5 Years from the SELECT-NEXT Study
  • Abstract Number: 1939
    Safety and Humoral Response Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-onset Autoimmune Inflammatory Rheumatic Diseases
  • Abstract Number: 0715
    Safety and Immunogenicity of Mixed COVID19 Vaccine Regimens in Immune-mediated Inflammatory Diseases: An Observational Cohort
  • Abstract Number: 1061
    Safety and Tolerability of Aminaphtone in Systemic Sclerosis Patients: A Four-year Follow-up
  • Abstract Number: 1077
    Safety of Avacopan in ANCA-Associated Vasculitis: Combined Data from Three Clinical Trials
  • Abstract Number: 2132
    Safety of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor: As Assessed by Laboratory Parameters – Results from a Phase 2 Trial in Psoriatic Arthritis and 2 Phase 3 Trials in Psoriasis
  • Abstract Number: 0280
    Safety of Filgotinib in Patients with RA: Laboratory Analysis Results from a Long-Term Extension Study
  • Abstract Number: 2120
    Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of 11 Phase 2/3 Clinical Studies in Psoriasis and Psoriatic Arthritis
  • Abstract Number: 1085
    Safety of Plasmapheresis as an Adjuvant Therapy in Severe Pediatric Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis: A Single Center Cohort
  • Abstract Number: 1765
    Safety of the Recombinant Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis Treated with JAKi Drugs
  • Abstract Number: 1635
    Safety Profile of Hydroxychloroquine in a Large Cohort of Rheumatology Patients Within the US Department of Defense Military Healthcare System
  • Abstract Number: 0988
    Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Enpatoran Doses in a Phase I Study of Healthy Japanese and Caucasian Participants: Feasibility of Including Asian Participants in a Phase II Study of Enpatoran
  • Abstract Number: 2244
    Salient Coping Strategies Among Youth with Chronic Musculoskeletal Pain
  • Abstract Number: 2023
    Salivary Autoantibodies in Sicca Patients Are Associated with Dry Symptoms
  • Abstract Number: 2024
    Salivary Gland Ultrasound May Lead to a More Accurate Stratification of Patients with the Same Serological Profile in Sjögren’s Syndrome: Towards a Personalized Approach
  • Abstract Number: 0136
    Sarcoidosis Incidence After mTOR Inhibitor Treatment
  • Abstract Number: 1111
    Sarcoidosis Rates in BCG-Vaccinated and Unvaccinated Young Adults: A Danish Register-Based Study
  • Abstract Number: 0160
    Sarcopenia in Myositis Patients: A Marker of Muscle Damage Associated with Myositis Severity and Disability
  • Abstract Number: 1676
    Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)
  • Abstract Number: 0511
    SARS-CoV-2 mRNA Vaccine Immunogenicity in Chronic Inflammatory Arthritis on DMARD Therapy
  • Abstract Number: 0796
    SARS-CoV-2 Vaccine in Axial Spondyloarthritis and Psoriatic Arthritis: Does Sulfasalazine Counterbalance TNFI Impaired Immunogenicity?
  • Abstract Number: 0993
    SARS-CoV-2 Vaccine Side Effects and Infections in SLE
  • Abstract Number: 0566
    SARS-CoV-2-Specific T Cell Responses in Multisystem Inflammatory Syndrome in Children
  • Abstract Number: 1343
    Satisfaction with Rheumatoid Arthritis Care Is Related to Discordance with Providers’ Treatment Goals and Patients’ Reasons for Disagreement
  • Abstract Number: 1836
    Schizophrenia and Its Relationship with Autoimmunity: A Nationwide Analysis
  • Abstract Number: 1166
    Scleroderma Fibroblasts Induce Alternative Macrophage Activation via an ERK1/2-dependent Mechanism
  • Abstract Number: 1046
    Scleroderma Heart Disease
  • Abstract Number: 1530
    Scleroderma Renal Crisis: Time to Initiation of Therapy Does Not Affect Mortality
  • Abstract Number: 2155
    Sclerodermoid Reaction Following Immune Checkpoint Inhibitor Therapy: A Case Series from MD Anderson Cancer Center
  • Abstract Number: 0329
    Scoring Personalized Molecular Portraits Identify Systemic Lupus Erythematosus Subtypes and Predict Individualized Drug Responses, Symptomatology and Disease Progression
  • Abstract Number: 1261
    Scoring Structural Damage in Rheumatoid Arthritis by Ultrasound: Results from a Delphi Process and Web-Based Reliability Exercise by the OMERACT Ultrasound Working Group
  • Abstract Number: 0234
    Scouting Reports as a Social Constructivist Teaching Tool in RheumMadness
  • Abstract Number: 0665
    Screening for Neurocognitive Demands in Childhood-onset Systemic Lupus Erythematosus Patients Using Pediatric Automated Neuropsychological Assessment Metrics and Association with Magnetic Resonance Imaging
  • Abstract Number: 0896
    Screening of Lipids in Patients with Rheumatoid Arthritis: Academic Rheumatology Practice Quality Improvement Analysis
  • Abstract Number: 1020
    Screening Tools for Spondyloarthritis in Patients with Psoriasis, IBD, and Uveitis – A Scoping Review
  • Abstract Number: PP06
    Search for a New Rheumatologist; What Happened When My Trusted Rheumatologist Retired
  • Abstract Number: 0495
    Seasonal Variation in the Incidence of GCA in the UK and Ireland
  • Abstract Number: 1193
    Seasonal Variation of Hospitalizations and In-Hospital Mortality Related to Systemic Lupus Erythematosus Among Adults in the United States: An Analysis of Nationwide Inpatient Sample
  • Abstract Number: 1323
    Secondary Prevention of Vertebral Fractures Sustained Efficacy over Time
  • Abstract Number: 1514
    Self-referral Strategy for Early Diagnosis of Axial Spondyloarthritis- Preliminary Analysis from Finding Axial Spondyloarthritis Study
  • Abstract Number: 0615
    Semaphorin 5A Suppresses Ferroptosis Through Activation of PI3K-AKT-mTOR Signaling in Rheumatoid Arthritis
  • Abstract Number: 0168
    Semiquantitative Thigh Magnetic Resonance Imaging (tMRI) in Determining Skeletal Muscle Outcomes at Baseline and on Follow up in Idiopathic Inflammatory Myopathies (IIMs)
  • Abstract Number: 0209
    Sensitivity of Three Skin-Specific Efficacy Outcomes to Detect Patient- and Physician-Reported Improvement in Overall Skin Disease in Dermatomyositis
  • Abstract Number: 2192
    Serious Infections in Offspring Exposed During Late Pregnancy to Tumour Necrosis Factor Inhibitors with High versus Low Placental Transfer Ability
  • Abstract Number: 1592
    Serious Infections in SLE- Incidence, Associated Factors, Impact and Trends over Two Decades
  • Abstract Number: 1980
    Seroconversion After a Third COVID-19 Vaccination in Rheumatoid Arthritis Patients Treated with (ultra-)low Dose Rituximab with a Previous Insufficient Humoral Response Is Associated with Rituximab Dosage
  • Abstract Number: 2048
    Serology Driven Pulmonary Phenotype Characterization of Sjögren Syndrome-associated Interstitial Lung Disease: A Monocentric Cohort Study
  • Abstract Number: 0889
    Serum Adipokines Predict Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis
  • Abstract Number: 2026
    Serum and Tear Autoantibodies from nor Mice as Potential Diagnostic Indicators of Local and Systemic Inflammation in Sjögren’s Syndrome
  • Abstract Number: 1554
    Serum Biomarkers in Association with Clinical and Vascular Disease Activity in Takayasu’s Arteritis
  • Abstract Number: 0960
    Serum C3 Level and Glucocorticoid Dose Are Risk Factors for Preterm Birth in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 0884
    Serum Calprotectin Can Differentiate Between Sustained Remission and Low Disease Activity States in Rheumatoid Arthritis
  • Abstract Number: 0883
    Serum Cholesterol Loading Capacity on Macrophages Is Dependent on Oxidized Low-density Lipoprotein and Regulated by Seropositivity and C-reactive Protein in Patients with Rheumatoid Arthritis
  • Abstract Number: 1447
    Serum Cytokine Profiling Reveals Elevated Levels of S100A8/A9 and MMP-9 in Systemic Lupus Erythematosus Patients with Cognitive Impairment Independently of Disease Activity and Inflammatory Markers
  • Abstract Number: 2129
    Serum Extracellular Matrix Biomarkers Identify Response to Guselkumab in Psoriatic Arthritis; Post-hoc Analysis from a Phase 3, Randomized, Double-blind, Placebo-controlled Study Through 2 Years
  • Abstract Number: 0652
    Serum from Patients with SLE and Anti-MDA5 Antibody-Positive Dermatomyositis Induce Shared Monocyte Cytokine Signature Through Type 1 Interferon Pathway
  • Abstract Number: 1156
    Serum Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Is Increased in Patients with Active Ankylosing Spondylitis (AS) and Persists Despite Anti-TNF Treatment
  • Abstract Number: 2171
    Serum IFN Score Predicts Long Term Outcome in Limited Cutaneous Systemic Sclerosis
  • Abstract Number: 0799
    Serum Laboratory Parameters of Hemophagocytic Lymphohistiocytosis Syndrome in Patients with Autoimmune Rheumatic Diseases Infected with SARS-CoV-2: A Retrospective Comparative Study
  • Abstract Number: 0660
    Serum Proteins and Metabolites Differ in SLE Patients with Coronary Microvascular Dysfunction (CMD) as Determined by Cardiac MRI Compared to SLE Patients Without CMD – a Pilot Study
  • Abstract Number: 0616
    Serum Proteomic Networks Associate with Pre-clinical Rheumatoid Arthritis Autoantibodies and Longitudinal Outcomes
  • Abstract Number: 0471
    Serum Proteomics in Giant Cell Arteritis: Findings of the Giant Cell Arteritis Treatment with Ultra-short Glucocorticoids and Tocilizumab Trial (The GUSTO Trial)
  • Abstract Number: 0636
    Serum Soluble Mediator Signatures of Lupus Nephritis Histological Features and Response to Treatment
  • Abstract Number: 0929
    Severe Low-Dose Methotrexate Toxicity in Elderly Patients with Inflammatory Rheumatic Diseases
  • Abstract Number: 0343
    Severe Non-adherence to Hydroxychloroquine Is Associated with Flares, Early Damage, and Mortality in Systemic Lupus Erythematosus: Data from 660 Patients from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
  • Abstract Number: 0705
    Severity of SARS-CoV-2 Omicron Breakthrough Infections in Patients with Rheumatic Immune-mediated Inflammatory Diseases and Healthy Controls: Data from a Prospective Cohort Study
  • Abstract Number: 0097
    Sex and Race/ethnicity Differences in Knee Symptoms, Function, and Radiographic Features: Preliminary Descriptive Data from the Johnston County Health Study
  • Abstract Number: 1101
    Sex and Racial Differences in Systemic Lupus Erythematosus Among U.S. Adults in the All of Us Research Program
  • Abstract Number: 0434
    Sex Based Differences in Cardiovascular Conditions Associated with Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Analysis of the National Inpatient Sample
  • Abstract Number: 1725
    Sex Differences in Autoimmune Pathogenesis and Systemic Response to High Fat Diet in Lupus-prone Mice
  • Abstract Number: 1967
    Sex Differences in Employment Outcomes in Patients with Recent Onset Rheumatoid Arthritis
  • Abstract Number: 0118
    Sex-Based Variations in Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions
  • Abstract Number: 1768
    Sex-Related Differences in Healthcare Utilization in Patients with Inflammatory Arthritis: A Population-based Study
  • Abstract Number: 1742
    Shared Epitope Allomorphs Directly Influence Antigen-specific T-cell Responses in RA
  • Abstract Number: 1122
    Short Peripheral Blood Leukocyte Telomere Length in Rheumatoid Arthritis – Interstitial Lung Disease
  • Abstract Number: 1463
    Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria
  • Abstract Number: 0107
    Short-, Intermediate- and Long-Term Renal Outcomes in Hispanics from Puerto Rico with Lupus Nephritis: Induction Therapy with Cyclophosphamide vs. Mycophenolate Mofetil
  • Abstract Number: 1375
    Short-term Efficacy of Baricitinib in Children with Refractory And/or Severe Juvenile Dermatomyositis
  • Abstract Number: 1052
    Short-term Safety of COVID-19 Vaccination in Systemic Sclerosis Patients: Report from a Global Patient-Reported E-survey
  • Abstract Number: 1249
    Short-term Variations in Subchondral Tibial Bone Texture of Conventional X-Rays Predicts Knee Osteoarthritis Progression
  • Abstract Number: 0126
    Should Arthrocentesis Be Attempted in the Symptomatic but Non-Effusive Knee?
  • Abstract Number: 0200
    Should Independence Play a Role in Assessing Remission in Rheumatoid Arthritis?
  • Abstract Number: 1908
    Should Osteoarthritis Patients with Pain Scores More Than 8/10 Be Analyzed Separately or Excluded from Clinical Trial Protocols, as 72% Screen Positive for Fibromyalgia And/or Depression on a Multidimensional Health Assessment Questionnaire (MDHAQ)?
  • Abstract Number: 0916
    Should RA Patients with Controlled Disease Taper Methotrexate from Targeted Therapy or Continue It? Risk Differences in Sustaining Remission from a Systematic Review and Meta-analysis
  • Abstract Number: 0348
    Significant Improvement in Cutaneous Lupus Erythematosus with or Without Systemic Lupus Erythematosus with Belimumab Use – a Systematic Review and Meta-Analysis
  • Abstract Number: 0026
    Silencing of WISP-2 Induces Inflammatory Mediators and Catabolic Factors in Cartilage
  • Abstract Number: 1619
    Silent Giant Cell Arteritis in Patients with Polymyalgia Rheumatica: Characteristics and Peculiarities
  • Abstract Number: 0684
    Single Antiphospholipid Antibody Positive Thrombotic APS Patients’ Clinical Characteristics: Retrospective Results from the APS ACTION Clinical Database and Repository (Registry)
  • Abstract Number: 1625
    Single Cell and Spatial Transcriptomics Identifies Pathogenic Drivers of Sjogren’s Disease in Humans
  • Abstract Number: 2041
    Single Cell Atlas of Minor Salivary Glands Reveals Key Differential Cellular and Functional Players in Sjögren’s and Sicca Syndrome
  • Abstract Number: 1179
    Single Cell RNA Sequencing Analysis of Cryopreserved versus Fresh Skin Biopsy Samples from Systemic Sclerosis Patients and Healthy Controls
  • Abstract Number: 2038
    Single Cell RNA Sequencing Points to a Role for Fibroblasts Early in Salivary Gland Dysfunction in Primary Sjögren’s Syndrome
  • Abstract Number: 1696
    Single Cell RNA-seq Identifies Major Shifts in Myeloid Cells in Dermatomyositis Skin and Peripheral Blood Compared to Systemic Lupus
  • Abstract Number: 1739
    Single-Cell Characterization of the TCR Repertoire Across Tissue and Blood in Rheumatoid Arthritis
  • Abstract Number: 1173
    Single-cell Multi-omic Analysis of a 3D Skin-Like Tissue Model Provides Insights into Molecular and Cellular Drivers of Systemic Sclerosis
  • Abstract Number: 0632
    Single-cell Multiomic Profiling Differentiates Ancestral B Cell Pathologies Contributing to Lupus Disease Activity
  • Abstract Number: 1630
    Single-cell Profiling of B Cell Repertoire and Gene Expression in the RA Synovium Reveals Tissue Specific Clonal Expansion
  • Abstract Number: 0501
    Single-molecule Spatial Transcriptomic Analysis Reveals Distinct Cellular Networks in Rheumatoid Arthritis Synovia
  • Abstract Number: 0404
    Site-Specific Responses of Joint and Entheses to Tofacitinib in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of a Phase 3 Trial
  • Abstract Number: 2042
    Sjögren’s Disease and Mitochondrial Function
  • Abstract Number: 1660
    Skeletal Myopathy in Systemic Sclerosis Associates with Higher Disease Burden and Mortality
  • Abstract Number: 1694
    Skin Exposure to UV Light Triggers Podocyte and Distal Tubular Injury, in the Presence of CD177+ Neutrophil Cell Cluster
  • Abstract Number: 1693
    Skin Pigmentation Association with Regulation of Cyclic-GMP-AMP Following Skin Exposure to UV Light
  • Abstract Number: 1729
    SLAMF4+ CCR5+ Effector Memory CD4+ T Cells Are Polyfunctional, Resistant to Exhaustion, and Expanded in Rheumatoid Arthritis
  • Abstract Number: 0642
    SLAMF6-SAP Signaling Unit Is Increased in SLE T Follicular Helper Cells
  • Abstract Number: 0387
    Sleep Quality in Patients with Psoriatic Arthritis and Its Relationship with Activity and Comorbidity
  • Abstract Number: 0327
    SMART-SLE: Serology Monitoring and Repeat Testing in Systemic Lupus Erythematosus
  • Abstract Number: 0881
    Social Cognitive Correlates of Accelerometer-measured and Self-reported Physical Activity in Persons with Systemic Lupus Erythematosus
  • Abstract Number: 0220
    Social Media Use in Academic Rheumatology
  • Abstract Number: 1782
    Sociocultural and Moral Factors Influencing the Decision to Vaccinate Among Rheumatic Patients: A Qualitative Study
  • Abstract Number: 0332
    Soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2) in Cerebrospinal Fluid Relating to Development of Diffuse Psychiatric/Neuropsychological Syndromes in Patients with Systemic Lupus Erythematosus (diffuse NPSLE)
  • Abstract Number: 1110
    Solving Sarcoidosis: A Transcriptome-based Meta-analysis of Clinical Sarcoidosis Studies Illustrates Shared Pathophysiology, Identifies Candidate Biomarkers and Suggests a Therapeutic Mechanism of JAK Inhibition
  • Abstract Number: 0478
    Sonographic Prevalence of Subclinical GCA in Newly Diagnosed PMR
  • Abstract Number: 0350
    Spanish National Registry of Belimumab in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1004
    SPARCC, MASES, LEI and MEI Indexes Capture Different Patients with Enthesitis in Axial Spondyloarthritis, Peripheral Spondyloartrhitis and Psoriatic Arthritis
  • Abstract Number: 2179
    Spatial and Single-Cell Transcriptomics Identify Alcam+ Macrophage / CD6+ T-Cell Interactions and Accumulation of IgG2b+ Class-Switched Plasma Cells in Marco+ Medullary Sinuses of Joint-Draining Popliteal Lymph Nodes in TNF-Tg Mice with Advanced Arthritis
  • Abstract Number: 0627
    Spatial Transcriptomic Analysis Reveals Vascular Zonation of Myofibroblasts in Rheumatoid Arthritis Synovium
  • Abstract Number: 1150
    Spatial Transcriptomics Stratifies Health and Psoriatic Disease Severity by Emergent Cellular Ecosystems
  • Abstract Number: 1225
    Sphygmomanometry for Fibromyalgia Detection in a Rheumatology Outpatient Clinic. a Cross-sectional Study
  • Abstract Number: 0868
    Spondyloarthritis and Neonatal Factors Affecting the Gut Microbiome
  • Abstract Number: 2253
    Sputum Cytokines Are Elevated in Rheumatoid Arthritis-Associated Interstitial Lung Disease
  • Abstract Number: 0533
    Sputum RA-Associated Autoantibodies Independently Associate with Future Development of Classified RA in an At-Risk Cohort of Individuals with Systemic Anti-CCP Positivity
  • Abstract Number: 2055
    SRI-4 and BICLA: How Well Do They Agree Across Trials of Active Systemic Lupus Erythematosus?
  • Abstract Number: 1762
    Stability of Cell Bound Complement Activation Products (CB-CAPs), Multianalyte Assay Panel (MAP) with Algorithm, and Other Autoimmune Biomarkers Among Clinical Patients Throughout the SARS-CoV-2 Pandemic and Vaccination Campaigns
  • Abstract Number: 0553
    Stair Climbing Difficulty and Risk of Functional Limitation in Knee Osteoarthritis: A Simple Functional Vital Sign?
  • Abstract Number: 1886
    Statin-induced Immune-mediated Miopathy: Treatment with Glucocorticoid-free Protocols and Role of Muscle Biopsy in the Follow-up
  • Abstract Number: 0353
    Steroid-Induced Diabetes in Lupus Nephritis Patients: Classic Risk Factors or a Different Type of Diabetes?
  • Abstract Number: 0038
    STING Antagonist (IFM4490) Inhibits STING Activation and STING Dependent Signal Transduction in Patients with STING-associated Vasculopathy with Onset in Infancy (SAVI)
  • Abstract Number: 1136
    Stratification of Systemic Lupus Erythematosus (SLE) Patients Based on the Molecular Patterns of Mouse Models
  • Abstract Number: 2050
    Stratification on Baseline Interferon Scores and Use of CRESS to Improve the Design of Future Trials in Sjögren’s Syndrome: Post Hoc Analysis from a Randomized Controlled Trial
  • Abstract Number: 1907
    Strength Training Associates with Less Knee Osteoarthritis: Data from the Osteoarthritis Initiative
  • Abstract Number: 2112
    Stringent Disease Activity Control at 2 Years Across Psoriatic Arthritis Domains Irrespective of Baseline Characteristics in Patients Treated with Guselkumab: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study
  • Abstract Number: 2142
    Strong Correlation Between Short- vs Long-form Composite Measures of Psoriatic Arthritis Disease Activity in a TNFi-IR Population Treated with Guselkumab: Data from the Phase 3b COSMOS Trial
  • Abstract Number: 0691
    Structural Differences Exist in Beta-2-Glycoprotein I from APS Patients Compared to Healthy Controls
  • Abstract Number: 1902
    Structural Severity in Knee Osteoarthritis Impacts Treatment Response: A Post Hoc Pooled Analysis of Lorecivivint Clinical Trials
  • Abstract Number: 2207
    Structural Ultrasound Features of Joints and Tendons of Healthy Children: Development of Normative Data
  • Abstract Number: 0108
    Study of the Level of Antibody Response to COVID-19 Vaccine in a Minority Population with Rheumatological Disorders
  • Abstract Number: 1410
    Subclinical Atherosclerosis Is Not Related with Acid Uric in Rheumatoid Arthritis: Study of 1005 Patients of a Single University Hospital
  • Abstract Number: 1856
    Subclinical Coronary Artery Disease in Patients with Idiopathic Inflammatory Myopathies: A Cross-Sectional Study Evaluation by Computer Tomography Coronary Angiogram
  • Abstract Number: 1216
    Subclinical Vascular Disease Is More Prevalent in above-30 Adult Fibromyalgia: A Preliminary Report of a Hospital-based Cross-sectional Study from South India
  • Abstract Number: 0643
    Subsetting SLE Patients Based on DNA Methylation at the Time of Disease Flare
  • Abstract Number: 1800
    Successful Establishment of Chronic Gouty Arthritis Model in C57BL/6 Mice
  • Abstract Number: 1369
    Sun Protection Use in Patients Followed in a Pediatric Rheumatology Clinic in an Urban Setting
  • Abstract Number: 1681
    Supernatants from Activated Macrophages Contain Citrullinated Vimentin and Induce Extracellular Matrix Deposition from Fibroblasts
  • Abstract Number: 0105
    Supplemental Primary Dose of the COVID-19 Vaccine in Immunosuppressed Patients on DMARDs and Biologic Agents
  • Abstract Number: 2079
    Survey to Prioritize and Generate Domains in Preparation to Update the OMERACT Core Domain Set for Systemic Lupus Erythematosus
  • Abstract Number: 0941
    Surveying Adolescents with Rheumatic Disease for At-Risk Behavior
  • Abstract Number: 0603
    Survivin-dependent Regulation of Bivalent Chromatin and Its Relevance for Adaptive Immunity
  • Abstract Number: 0790
    Sustainability of Immunogenicity of BNT162b2 Vaccine in Patients with Autoimmune Rheumatic Disease, a Retrospective Comparative Study
  • Abstract Number: 2065
    Sustained B Cell Depletion in Lupus Nephritis Patients After Treatment with a B Cell Agent Is Associated with Fewer Disease Flares
  • Abstract Number: 1586
    Sustained Remission Following the Discontinuation of Tofacitinib in Patients with Rheumatoid Arthritis (XANADU Study): A Multicenter, Prospective, and Randomized Controlled Study
  • Abstract Number: 2139
    Sustained Response to Guselkumab Regardless of Baseline Demographic, Disease, and Medication Characteristics in Patients with Active Psoriatic Arthritis and an Inadequate Response to TNF Inhibitors: Results from a Phase 3b Trial
  • Abstract Number: 0534
    Synovial Transcriptomic Profiles Correlate with Disease Activity in Early Untreated Rheumatoid Arthritis
  • Abstract Number: 1964
    Systematic Screening of Multimorbidities Results in an Increased Intake of Comorbidity Preventive Medications and a Decreased Hospitalization Rate
  • Abstract Number: 1650
    Systemic Immune Inflammation Index Predict All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
  • Abstract Number: 1321
    Systemic Inflammatory-based Scores and Bone Turnover Ratio as Novel Diagnostic Tools for Chronic Nonbacterial Osteomyelitis (CNO) of the Sternocostoclavicular Region in Adults
  • Abstract Number: 0859
    Systemic Juvenile Idiopathic Arthritis Associated Lung Disease in Europe
  • Abstract Number: 1458
    Systemic Lupus Erythematosus (SLE) Patients with Cognitive Impairment Experience More Fatigue Compared to Patients Without Impairment
  • Abstract Number: 0949
    Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic CHallenge (SWITCH): The Systemic Lupus International Collaborating Clinics Experience
  • Abstract Number: 1170
    Systemic Sclerosis Dermal Fibroblast-derived Exosomes Trigger a Type 1 Interferon Rresponse in Keratinocytes Through TBK1
  • Abstract Number: 2162
    Systemic Sclerosis in Alaska Native/American Indian People in Alaska
  • Abstract Number: 1731
    Systemic Sclerosis-Associated Class II HLA Alleles Restrict the Diversity of the CDR3 and the T Cell Receptor Repertoire in African American Patients
Jump to:  View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology